Growth patterns of screen-detected malignant pulmonary nodules: Accuracy of doubling-time models
Andrew Creamer(University College London), Sam M. Janes(University College London), Priyam Verghese(University College London), Carolyn Horst(University College London), Anand Devaraj(Royal Brompton & Harefield NHS Foundation Trust), Sophie Tisi(University College London), Jennifer Dickson(University College London Hospitals NHS Foundation Trust), Kylie Gyertson(University College London Hospitals NHS Foundation Trust), Laura Farrelly(University College London), Helen Hall(University College London), Arjun Nair(Philadelphia College of Osteopathic Medicine), Ruth Prendecki(University College London), Anne-Marie Hacker(Cancer Research UK), John McCabe(University College London), Amyn Bhamani(University College London), Jonathan Teague(Cancer Research UK), Allan Hackshaw(Cancer Research UK)
Cited by 1
Related Papers
First-Trimester or Second-Trimester Screening, or Both, for Down's Syndrome
|New England Journal of Medicine|2005|1.1k
Single-cell multi-omics analysis of the immune response in COVID-19
|Nature Medicine|2021|826
Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial
|The Lancet Respiratory Medicine|2020|558
Infectious diseases in the aftermath of monsoon flooding in Pakistan
|Asian Pacific Journal of Tropical Biomedicine|2011|103